Switching From Reference to Biosimilar Etanercept for Patients with Plaque Psoriasis

Details

Files

Project Line:

Reference List

Project Sub Line:

Summary of Abstracts

Project Number:

RB1553-000

Question

What is the clinical effectiveness of switching from reference to biosimilar etanercept in adult or pediatric patients with plaque psoriasis?

Key Message

Two randomized controlled trials were identified regarding the clinical effectiveness of switching from reference etanercept to biosimilar etanercept in adult or pediatric patients with plaque psoriasis.

Files

Switching From Reference to Biosimilar Etanercept for Patients with Plaque Psoriasis Rapid Response February 12, 2021 View PDF

Last Updated : February 18, 2021